0
How does Myriad conduct BART testing?
- 1 people answered
0 Vote
1 Contributor
1551 Views 
0 Saved
0 Vote 1 Contributor1551 Views 0 SavedYou might also be interested in
There are few things more alarming than battling cancer. One is not having the money for its treatment. Given the recent spike in incidence of cancer and its treatment costs, this could soon be a reality than mere speculation. At present breast cancer treatment in India costs almost 6 lakhs, while i....
Understanding the difference between chemotherapy and radiation treatment can help you be more prepared for visits to your doctor. Various treatment options are available for patients suffering from cancer. Based on the type and stage of cancer, when the patient is diagnosed, patient’s overall he....
Cancer attacks your body due to a random mutation of cells that gets out of control and spreads. The majority of breast cancers are hereditary, or blind unlucky chance. Fat is not directly linked with the enhanced cancer risk factor but it affects the estrogen hormone balance in your body which play....
Mahima Chaudhary
Imagine going in for a cancer screening, and the technician turns to you and says, "We're finished, but if I push this button over here, the machine can detect even smaller cancers. But here's the hitch: You have to pay $700 if you want me to push this button."
Myriad Genetics is doing something very similar with BART tests that determine if a woman has a potentially dangerous genetic abnormality linked to breast cancers.
When testing shows that a woman carries a bad gene, she has a much higher chance of getting breast cancer. These women usually then get more frequent MRIs, ultrasounds and mammograms to detect cancer.
Myriad owns the patent on breast cancer genes and so is the only company that can test for them. It offers one test that catches most, but not all, abnormalities, and then charges nearly all patients $700 for a second test that catches the rest.
If a woman can't afford the $700 fee, she may miss an abnormality, which could mean the difference between life and death.
Myriad defends the $700 charge for its second test, called BART, even though many patients can't afford it and insurance won't pay for it.